BDBM179881 US10231963, Table B.27::US10287250, Compound B.9::US10736890, Compound TABLE B.27::US10752592, Compound TABLE B.9::US11534436, Compound Table B.27::US9133125, Table B, Compound 9::US9656961, Example 00144

SMILES C=C1CC[C@@]2(O)[C@H]3Cc4ccc(C(N)=O)c(O)c4[C@@]2(CCN3CC=C(C)C)C1

InChI Key InChIKey=DUFZCRAEMOSUOA-UHFFFAOYSA-N

Data  7 KI  7 IC50  5 EC50

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 18 hits for monomerid = 179881   

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/4/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
2/20/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
2/27/2020
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/27/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/8/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/11/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataKi:  0.5nM ΔG°:  -12.7kcal/mole IC50: 51nMpH: 7.5 T: 2°CAssay Description:The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal o...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
5/16/2016
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataEC50:  15nMAssay Description:The EC50 and Imax for μ opioid receptors was determined using a [35S]GTPγS binding assay. This assay measures the functional properties of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
2/27/2020
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataEC50:  15nMpH: 7.4Assay Description:The EC50 and Imax for mu opioid receptors was determined using a [I35S]GTPgammaS binding assay. This assay measures the functional properties of a co...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
5/16/2016
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataEC50:  15nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/27/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataEC50:  15nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/11/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataEC50:  15nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/8/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/4/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/27/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
2/20/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
2/27/2020
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/11/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetMu-type opioid receptor(Human)
Alkermes Pharma Ireland

US Patent

LigandBDBM179881(US9133125, Table B, Compound 9 | US9656961, Exampl...)Copy SMILESCopy InChI

Affinity DataIC50: 51nMAssay Description:The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
4/8/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL